pharmaceutical investing Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA
pharmaceutical investing Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease
pharmaceutical investing Abeona Therapeutics Receives FDA Rare Pediatric Disease Designation for ABO-202 Gene Therapy Program in CLN1 Disease
Agios Receives FDA Priority Review for New Drug Application: How are Gene Therapy Drug Approvals Impacting Stocks?
pharmaceutical investing Abeona Therapeutics Reports Top-Line Data from Phase 1/2 Gene Therapy Trial in MPS IIIA
80 Mile PLC Secures 3 Strategic MOUs with Fortune 500 Energy Group, Ludoil, and JEnergy and moves to 100% of Ferrandina Biofuels Plant
Cotec Purchases Commercial Scale Salter Cyclone Multi-Gravity-Separator Unit to be Located at Corem Québec, Canada
TSX-V: TT Closes Acquisition of High Lake and West Hawk Lake from McFarlane Lake Mining and Closing of Final Tranche of Non-Brokered Private Placement
Element One Hydrogen and Critical Minerals Announces Letter of Intent to Acquire Hydrogen and Critical Mineral Extraction Technology
